The results showed that oemiR-325 could partly reverse shAR's function to HCC cells (Figure 3J-L), while adding miR-325 inhibitor could partly reverse oeAR's function to HCC cells (Figure 3M-O), which indicated that miR-325 could be regulated by AR to regulate HCC progression. Here, AR is linked to hepatocellular carcinoma.